|| Checking for direct PDF access through Ovid
Recently, CD32 has been described to be a specific surface marker of latently HIV-infected CD4+ T cells, but little is known about the frequency and distribution of CD32 expression on naive and memory CD8+ and CD4+ T cell populations in HIV patients and healthy individuals.We studied peripheral blood samples of 36 HIV-1–infected patients [23 viremic patients / 13 antiretroviral therapy(ART)–treated] and healthy individuals (n = 14) as well as cells from lymph nodes (8 HIV infected, 5 controls) using a multiparametric flow cytometry panel determining surface expression of CD3, CD8, CD4, CD45RA, CCR7, CD27, CD25, CD127, CCR5, CCR6, CXCR4, CD38, HLA-DR, TIGIT, and PD-1.Overall, expression of CD32 on total peripheral CD4+ T cells between viremic HIV patients, ART-treated and healthy individuals only slightly differed (mean values 1.501%, 0.2785%, and 0.2343%, respectively). However, the level of expression was significantly higher in peripheral and lymph nodal memory CD4+ T cell subpopulations of viremic patients compared with ART-treated patients and healthy controls. CD32+ CD4+ T cells showed higher immune activation and higher expression of CXCR4+ than their CD32− counterparts. Furthermore, expression of CD32 on total CD4+ T cells and memory T cell populations correlated with general immune activation regardless of the infection status.Follow-up studies will have to further evaluate CD32 as marker of latently HIV-infected CD4+ T cells since other host-related variables such as immune activation seem to influence CD32 expression regardless of the infection status.